From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Actual | Predicted (95% CI) | Difference | |
---|---|---|---|
Symptom group | |||
Asymptomatic | 0.923 | 0.893 (0.819; 0.967) | 0.030 |
Mildly symptomatic | 0.806 | 0.833 (0.783; 0.883) | −0.027 |
Moderately symptomatic | 0.675 | 0.679 (0.616; 0.743) | −0.004 |
Severely symptomatic | 0.501 | 0.474 (0.398; 0.551) | 0.027 |